2016 ReviewYear ended March 2016

Scroll to learn more

Meiji's Business

The Meiji Group provides customers of all ages ―from infants to seniors― with a wide range of products for healthy and fulfilling lives. From delicious confectionaries and wholesome dairy products to body-enhancing nutrition supplements and vital pharmaceuticals, we make people's wellness our main mission.

Meiji's Business

Key Figures

Net Sales
¥1,223.7 billion
5.4%
Operating Income Ratio
6.4 %
2.0 percentage points
Capital Expenditures
¥42.3 billion
34.2%
Operating Income
¥77.7 billion
50.9%
ROE
16.1 %
7.2 percentage points
R&D Expenses
¥27.3 billion
4.6%

Breakdown by Segment

Breakdown by Segment

Business Performance Analysis

Food

Net Sales
¥1,061.3 billion
3.9%
Operating Income
¥68.2 billion
63.9%

Income Analysis

Pharmaceuticals

Net Sales
¥164.5 billion
16.4%
Operating Income
¥10.1 billion
0.4%

Income Analysis

Capital Expenditures

Capital Expenditures

Food

¥36.5 billion

Pharmaceuticals

¥5.7 billion

Cash Dividends per Share / Dividend Payout Ratio

Dividend Payout Ratio / Cash Dividends per Share

Future Prospects

For the Second year of our STEP UP 17 initiative in FYE March 2017,
our consolidated earnings forecast is as follows:

FYE 3/2016
Results
Net sales ¥1,223.7 billion
Operating income ¥77.7 billion
Operating income ratio 6.4%
ROE 16.1%

FYE 3/2017
Targets
¥1,251.0 billion
¥84.5 billion
6.8%
13%

(as of Feb 7, 2017)